Coronavirus Notebook: Remdesivir Supply Dwindles; US FDA Signs Another RWE Deal; Corning Gets BARDA Contract For Glass Vials

Dispatches from a world turned upside down also include changes in drug sample distribution guidelines and further reductions in the hours of FDA’s COVID hotline.

Covid19_Cell_Microscope

The US federal government will have allocated nearly all of Gilead Sciences Inc.’s donated remdesivir to treat COVID-19 patients by June 29, an HHS spokesperson told the Pink Sheet. Less than two percent of the donation “is being held in reserve” for any “hotspots,” that emerge, the spokesperson added.

HHS said it is discussing with Gilead when more inventory will be available. It did not answer questions as to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Real-World Evidence

More from Clinical Trials